Clinical Conversations

Clinical Conversations

Download on the App Store

All Clinical Conversations episodes

  • Podcast 74: How two SSRIs apparently interfere with tamoxifen therapy.

    We talk with Dr. Catherine Kelly about her study in  BMJ showing serious interference of some SSRIs with tamoxifen therapy in breast cancer. The study was conducted using Canadian provincial databases.

    Reach us at 1-617-440-4374 or by email to [email protected].

    Interview article:

    • BMJ study
    • Physician’s First Watch coverage
    • Medical news links:

      • Back pain guidelines
      • Inflammatory bowel disease and venous thromboembolism
      • Automated calling systems
      • The post Podcast 74: How two SSRIs apparently interfere with tamoxifen therapy. first appeared on Clinical Conversations.
        15 min
      • Podcast 73: How best to monitor patients on androgen-deprivation therapy for cardiovascular risks?

        A panel of the American Heart Association, the American Cancer Society, and the American Urological Association issued a statement on androgen-deprivation therapy and cardiovascular risk. We’ve got an interview with the chair of the writing committee, Dr. Glenn Levine.

        Interview-related links:

        • Physician’s First Watch coverage of the statement
        • Link to the statement, as published in Circulation
        • News-related links:

          • Lancet retracts 1998 paper linking MMR vaccination and autism
          • Use prefilled Sanofi Pasteur N1N1 vaccines before mid-February
          • JAMA study on proteinuria
          • If you’d like to contact Clinical Conversations, call 1-617-440-4374 or write to [email protected]

            The post Podcast 73: How best to monitor patients on androgen-deprivation therapy for cardiovascular risks? first appeared on Clinical Conversations.
            13 min
          • Podcast 72: A conversation about two new drugs for multiple sclerosis.

            We’ve got Dr. William Carroll this week — we tried last week, but the 13-hour time difference between Boston and Perth just stymied me. Dr. Carroll speaks about his NEJM editorial concerning two new drugs for multiple sclerosis. Both are oral therapies that work to keep lymphocytes at bay in this disease.

            Interview-story link:

            • MS Treatments Said to Offer ‘New Horizon’
            • News links:

              • New York Times series on radiation safety
              • Lancet study on glycated hemoglobin levels
              • FDA approval of diabetes drug
              • JNCI study on ovarian cancer symptoms
              • The post Podcast 72: A conversation about two new drugs for multiple sclerosis. first appeared on Clinical Conversations.
                12 min
              • Podcast 71: We revisit, after a look at current clinical news, a conversation on the late clinical course of dementia.

                I tried arranging an interview across a 13-hour time difference, with no luck. We revisit, instead, an October conversation about the late clinical course of dementia.

                First a look at the news.

                Comments to [email protected] or to 1-617-440-4374.

                Interview link:

                • Advanced Dementia’s Course
                • News links:

                  • Massachusetts elects a U.S. Senator
                  • Screening and treating children for overweight
                  • Abnormal lipid profiles found in many U.S. adolescents
                  • Quitting smoking after early-stage cancer diagnosis lengthens survival
                  • The post Podcast 71: We revisit, after a look at current clinical news, a conversation on the late clinical course of dementia. first appeared on Clinical Conversations.
                    12 min
                  • Podcast 70: Considering the USPSTF breast-screening guidelines with your patients

                    This is the podcast for January 15, 2010.

                    We have an interview on the impact of the USPSTF guidelines with two clinicians who study the best ways to communicate clearly with patients. I think you’ll like it.

                    You can reach me at [email protected] or by calling 617-440-4374. If you like this podcast, there are many others in the archives, and they’re all free. I hope you find them useful.

                    News links:

                    Adult immunization schedule in MMWR

                    Ticagrelor versus clopidogrel

                    Platelet-rich plasma injections

                    Lack of evidence supporting rapid response teams

                    Inerview linki:

                    JAMA essays on USPSTF recommendation

                    The post Podcast 70: Considering the USPSTF breast-screening guidelines with your patients first appeared on Clinical Conversations.
                    18 min
                  • Podcast 69: Eating soy foods and survival after breast cancer

                    I’ve been on vacation, and I hope that you’ve managed to sneak some time away as well.

                    In December, JAMA published an article associating increased survival after breast cancer with eating even modest amounts of soy food regularly. The work was done using a cohort in Shanghai, and the study’s first author agreed to an interview.

                    If you have comments (and there seems to have been more over the holidays, for some reason) please feel free to chime in. I’ll be better about evaluating them promptly for appropriateness.

                    You can also leave voice mail at 1-617-440-4374 and email me at [email protected].

                    Here are the week’s links:

                    Interview-related–

                    JAMA abstract

                    News-related–

                    Atypical antipsychotics

                    Presurgical prep

                    High-test flu shot for elders

                    Contaminated cocaine and agranulocytosis

                    The post Podcast 69: Eating soy foods and survival after breast cancer first appeared on Clinical Conversations.
                    15 min
                  • Podcast 68: Change your approach to pharyngitis in adolescents and young adults.

                    Dr. Robert Centor of the University of Alabama at Birmingham believes that the paradigm for treating pharyngitis in adolescents and young adults must change. Listen to our conversation and hear why.

                    Here are this week’s links:

                    Interview:

                    • Commentary Urges ‘Expanding the Diagnostic Paradigm of Pharyngitis’ in Young People
                    • Robert Centor’s blog — “Medrants”
                    • News stories:

                      • Chronic Pain Linked to Greater Risk for Falls in the Elderly
                        • Even Very Low Levels of Cardiac Troponin T Linked to Heart Failure, Cardiovascular Death
                          • Length of ICU Stay Closely Linked to Infection Rate, International Survey Shows
                            • Norpramin Label Updated to Warn of Use in Patients with Family Histories of Sudden Death, Cardiac Dysrhythmias
                              • Postoperative VTE Risk in Women Remains Substantially Elevated for 12 Weeks
                              • The post Podcast 68: Change your approach to pharyngitis in adolescents and young adults. first appeared on Clinical Conversations.
                                15 min
                              • Podcast 67: Unexpected “incidental” findings on pulmonary CT angiography present problems of pursuit and follow-up.

                                This week’s Archives of Internal Medicine investigates what happens when you analyze the outcome of all those pulmonary angiographic CTs ordered in the emergency department to rule out pulmonary embolism.

                                We talk things over with Dr. Shannon Carson and Dr. William Hall, two of the paper’s principal authors.

                                It’s Thanksgiving Week here in the U.S., and so there won’t be a news section in this edition. I’ll catch you up next week on what’s happened.

                                I hope your holiday is pleasant, if you get one, and your workload reasonable, if you don’t.

                                Interview link:

                                • CT Testing for Pulmonary Embolism Is More Likely to Yield Burdensome ‘Incidental Findings’
                                • The post Podcast 67: Unexpected “incidental” findings on pulmonary CT angiography present problems of pursuit and follow-up. first appeared on Clinical Conversations.
                                  15 min
                                • Podcast 66: Niacin versus ezetimibe in the face of high cardiovascular risk — a conversation with the ARBITER 6-HALTS trialist Allen Taylor

                                  One of the more intriguing pieces of research presented at the American Heart Association this week (and simultaneously released online in the New England Journal of Medicine) shows that extended-release niacin outperforms ezetimibe in high-risk patients. We talk with Dr. Allen J. Taylor, the study’s first author.

                                  Contact us at 1-617-440-4374 or write [email protected].

                                  This edition’s links:

                                  Interview Link:

                                  • Extended-Release Niacin Outperforms Ezetimibe in Lowering Cardiovascular Risk
                                  • News Links:

                                    • USPSTF Recommends Against Routine Mammography for Women in Their 40s
                                    • ACOG Releases New Cervical Screening Guidelines into Politically Charged Environment
                                    • FDA Approves New Treatment for Shingles-Related Pain
                                    • The post Podcast 66: Niacin versus ezetimibe in the face of high cardiovascular risk — a conversation with the ARBITER 6-HALTS trialist Allen Taylor first appeared on Clinical Conversations.
                                      18 min
                                    • Podcast 65: A conversation about the utility of renovascular angioplasty in the face of atherosclerosis

                                      Investigators have suspected that there isn’t much advantage to renovascular angioplasty and stenting in atherosclerosis, but their studies haven’t had the statistical power to prove that point. A new bit of research in this week’s New England Journal of Medicine may have hit the mark. We’ve got an interview with two of the principals of the ASTRAL study (that’s their acronym for Angioplasty and Stenting for Renal Artery Lesions). Dr. Philip Kalra, the nephrology lead, and Dr. Jonathan Moss, the radiology lead, kindly agreed to the conversation, which I think you’ll find of interest.

                                      Reach us with your comments and suggestions at [email protected], or call 1-617-440-4374.

                                      This edition’s links:
                                      Interview link–
                                      • No Clinical Benefits of Revascularization in Atherosclerotic Renal Arteries
                                      • News links–
                                        • H1N1 Update: Estimates of Flu’s Toll; Seasonal Vaccine Not Effective Against 2009 H1N1
                                        • Prone Position for Acute Respiratory Distress Syndrome Doesn’t Boost Survival
                                        • The post Podcast 65: A conversation about the utility of renovascular angioplasty in the face of atherosclerosis first appeared on Clinical Conversations.
                                          15 min